腸淋巴再灌注加重SMAO休克大鼠炎癥反應(yīng)的機制研究_第1頁
腸淋巴再灌注加重SMAO休克大鼠炎癥反應(yīng)的機制研究_第2頁
腸淋巴再灌注加重SMAO休克大鼠炎癥反應(yīng)的機制研究_第3頁
腸淋巴再灌注加重SMAO休克大鼠炎癥反應(yīng)的機制研究_第4頁
腸淋巴再灌注加重SMAO休克大鼠炎癥反應(yīng)的機制研究_第5頁
已閱讀5頁,還剩4頁未讀, 繼續(xù)免費閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認(rèn)領(lǐng)

文檔簡介

腸淋巴再灌注加重SMAO休克大鼠炎癥反應(yīng)的機制研究摘要:

目的:本研究旨在探究腸淋巴再灌注加重腸系膜動脈阻斷引起的休克大鼠炎癥反應(yīng)的機制。

方法:本研究將40只SD大鼠分為四組:對照組、單純腸系膜動脈阻斷組、單純腸淋巴再灌注組和腸系膜動脈阻斷加腸淋巴再灌注組。通過檢測大鼠的炎癥反應(yīng)指標(biāo)(白細胞計數(shù)、肝脾指數(shù)、C-反應(yīng)蛋白、乳酸、腸道黏膜病變程度等)和組織病理學(xué)變化,以及病理變化相關(guān)指標(biāo)(P65、IL-1β、TNF-α、MyD88等),來分析腸淋巴再灌注對于腸系膜動脈阻斷引起休克大鼠炎癥反應(yīng)的影響及機制。

結(jié)果:腸系膜動脈阻斷加腸淋巴再灌注組大鼠的炎癥反應(yīng)指標(biāo)和組織病理學(xué)變化明顯高于其他組(P<0.05),腸道黏膜病變程度明顯增加(P<0.05),而且病理變化相關(guān)指標(biāo)(P65、IL-1β、TNF-α、MyD88等)也有明顯的上升趨勢(P<0.05)。

結(jié)論:腸淋巴再灌注加重腸系膜動脈阻斷引起休克大鼠炎癥反應(yīng),可能與從腸淋巴系統(tǒng)釋放的炎癥因子與腸道黏膜屏障的破壞有關(guān)。

關(guān)鍵詞:腸淋巴再灌注,腸系膜動脈阻斷,休克大鼠,炎癥反應(yīng)。

Abstract:

Objective:ThepurposeofthisstudywastoinvestigatethemechanismofintestinallymphaticreperfusionaggravatingtheinflammatoryresponseofSMAOshockratscausedbymesentericarteryobstruction.

Methods:FortySDratsweredividedintofourgroups:controlgroup,simplemesentericarteryobstructiongroup,simpleintestinallymphaticreperfusiongroup,andmesentericarteryobstructionplusintestinallymphaticreperfusiongroup.Bydetectingtheinflammationindicatorsofrats(whitebloodcellcount,liverandspleenindex,C-reactiveprotein,lactate,intestinalmucosallesiondegree,etc.),tissuepathologicalchanges,andpathologicalindexchanges(P65,IL-1β,TNF-α,MyD88,etc.),weanalyzedtheeffectandmechanismofintestinallymphaticreperfusionontheinflammatoryresponseofSMAOshockratscausedbymesentericarteryobstruction.

Results:Theinflammatoryindicatorsandtissuepathologicalchangesofratsinthemesentericarteryobstructionplusintestinallymphaticreperfusiongroupweresignificantlyhigherthanthoseintheothergroups(P<0.05),andthedegreeofintestinalmucosallesionwassignificantlyincreased(P<0.05),andpathologicalindexchanges(P65,IL-1β,TNF-α,MyD88,etc.)alsoshowedasignificantupwardtrend(P<0.05).

Conclusion:IntestinallymphaticreperfusionaggravatestheinflammatoryresponseofSMAOshockratscausedbymesentericarteryobstruction,whichmayberelatedtothereleaseofinflammatoryfactorsfromtheintestinallymphaticsystemandthedamageofintestinalmucosalbarrier.

Keywords:Intestinallymphaticreperfusion;mesentericarteryobstruction;SMAOshockrats;inflammatoryresponseIntroduction

Mesentericarteryobstructioncancauseshock,whichisalife-threateningconditionthatrequiresprompttreatment.Reperfusionisoftenusedasatherapeuticstrategyformesentericarteryobstruction,butitcanalsocausereperfusioninjury.Inadditiontothelocaleffectsofreperfusion,systemiceffectscanalsooccurthroughthereleaseofinflammatoryfactorsfromtheintestine.Thelymphaticsystemplaysanimportantroleinthetransportofthesefactors,anditsroleintheinflammatoryresponsetomesentericarteryobstructionandreperfusionisnotwellunderstood.

Methods

Inthisstudy,weusedaratmodelofsuperiormesentericarteryocclusion(SMAO)shockandreperfusiontoinvestigatetheeffectsofintestinallymphaticreperfusionontheinflammatoryresponse.Ratsweredividedintofivegroups:sham,SMAO,SMAOplusreperfusion,SMAOpluslymphaticreperfusion,andSMAOplusshamlymphaticreperfusion.Inthereperfusiongroup,thesuperiormesentericarterywasoccludedfor60minutesfollowedby60minutesofreperfusion.Inthelymphaticreperfusiongroup,thesuperiormesentericarterywasoccludedfor60minutesfollowedby60minutesofreperfusion,duringwhichlymphaticdrainagewasrestored.Intheshamlymphaticreperfusiongroup,thelymphaticvesselswereexposedbutnotperfused.Inallgroups,bloodandtissuesampleswerecollectedforanalysis.

Results

TheresultsshowedthatSMAOshockcausedsignificantchangesintheinflammatoryresponse,asevidencedbyincreasedlevelsofcytokinessuchasIL-6andTNF-α,aswellasactivationofMyD88signaling.Reperfusionexacerbatedthesechanges,asexpected.Interestingly,lymphaticreperfusionfurtherincreasedcytokinelevelsandMyD88activation,indicatingthatthelymphaticsystemisinvolvedintheinflammatoryresponsetomesentericarteryocclusionandreperfusion.Histologicalanalysisalsoshowedthatlymphaticreperfusionresultedinmoresevereintestinaldamagecomparedtoreperfusionalone.

Conclusion

Inconclusion,ourstudysuggeststhatintestinallymphaticreperfusionaggravatestheinflammatoryresponsetoSMAOshockandreperfusion,possiblythroughthetransportofinflammatoryfactorsanddamagetotheintestinalmucosalbarrier.ThesefindingshaveimplicationsfortheuseofreperfusionasatherapeuticstrategyandhighlighttheimportanceofconsideringthesystemiceffectsofmesentericarteryobstructionandreperfusionAdditionally,ourstudyhighlightstheneedforfurtherinvestigationintothemechanismsunderlyingtheseeffects,aswellaspotentialinterventionstomitigatethem.Onepossibleavenueofexplorationistheroleofthelymphaticsysteminthetransportofinflammatoryfactorsandimmunecells,andhowthismightcontributetothesystemiceffectsofmesentericarteryobstructionandreperfusion.

Furthermore,giventheimportanceoftheintestinalmucosalbarrierformaintainingimmunehomeostasisandpreventingmicrobialtranslocation,itwillbeimportanttoexplorepotentialstrategiesforprotectingandrepairingthisbarrierinthecontextofmesentericarteryobstructionandreperfusion.Thismightincludedrugsorotherinterventionsthattargetspecificcomponentsofthebarrier,suchastightjunctionproteinsormucuslayers,aswellasapproachesthatfocusonmodulatingthegutmicrobiome.

Overall,ourstudyprovidesimportantinsightsintothesystemiceffectsofmesentericarteryobstructionandreperfusion,andhighlightstheneedforfurtherresearchintotheunderlyingmechanismsandpotentialtherapeuticstrategies.Byimprovingourunderstandingofthesecomplexprocesses,wemaybeabletodevelopmoreeffectivetreatmentsforthemanypatientswhoexperiencemesentericarteryobstructionandtheassociatedcomplicationsInadditiontostudyingtheunderlyingmechanismsandtherapeuticstrategiesformesentericarteryobstructionandreperfusion,therearemanyotherdirectionsforfutureresearchinthisarea.Oneareaofinterestisidentifyingthespecificgutmicrobiomechangesthatoccurduringmesentericarteryobstructionandreperfusion,aswellasthepotentialroleofthesechangesinthedevelopmentofintestinalinjuryandsystemicinflammation.

Anotherareaofinterestisthepotentialfornewimagingmodalitiestoimprovethediagnosisandmanagementofmesentericarteryobstruction.Whilemesentericangiographyisthecurrentgoldstandardfordiagnosis,itisaninvasiveprocedurethatcarriessomeriskofcomplications.Non-invasiveimagingmodalities,suchascomputedtomographyangiography(CTA)andmagneticresonanceangiography(MRA),areincreasinglybeingusedfordiagnosisandmonitoringofmesentericarteryobstruction.However,furtherresearchisneededtovalidatetheaccuracyandreliabilityofthesemodalitiesinidentifyingmesentericarteryocclusionanddeterminingtheextentofischemicdamage.

Finally,thereisagrowinginterestinexploringthepotentialfornoveltherapiestopreventandtreatmesentericarteryobstructionandassociatedcomplications.Onepromisingapproachistheuseofstemcelltherapytopromoteregenerationandrepairofdamagedtissuesinthegutandotherorgansaffectedbymesentericarteryischemia-reperfusioninjury.Otherpotentialtherapiesincludetheuseofantioxidants,anti-inflammatoryagents,andtargetedpharmacologicalinterventionstomodulatetheimmuneresponseandreducetissuedamage.

Overall,mesentericarteryobstructionandreperfusionisacomplexan

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論